BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 6157397)

  • 1. Clinical pharmacology of hydroxyethyl starches.
    Mishler JM
    Rev Fr Transfus Immunohematol; 1980; 23(3):283-98. PubMed ID: 6157397
    [No Abstract]   [Full Text] [Related]  

  • 2. [Intravascular persistence, tissue storage and excretion of hydroxyethyl starch (HAS)].
    Thompson WL; Fukushima T; Rutherford RB; Walton RP
    Infusionsther Klin Ernahr; 1979 Jun; 6(3):151-5. PubMed ID: 88413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of low molecular hydroxyethyl starch (HES) on the kidney -- a comparison with low molecular dextran].
    Yamasaki H
    Masui; 1975 Jun; 24(6):580-600. PubMed ID: 51106
    [No Abstract]   [Full Text] [Related]  

  • 4. [Second increase in plasma volume after single infusion of hydroxyethyl starch (author's transl)].
    Köhler H; Kirch W; Pitz H
    Klin Wochenschr; 1978 Oct; 56(19):977-83. PubMed ID: 81905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Physicochemical and biological properties of hydroxyethyl starch].
    Polushina TV; Prostakova TM; Andrianova IuI; Luk'ianova NA; Kuznetsova VM
    Probl Gematol Pereliv Krovi; 1980 Sep; 25(9):12-5. PubMed ID: 6158737
    [No Abstract]   [Full Text] [Related]  

  • 6. [The effects of 500 ml 10% hydroxyethyl starch 200/0.5 and 10% dextran 40 on blood volume, colloid osmotic pressure and renal function in human volunteers (author's transl)].
    Köhler H; Zschiedrich H; Clasen R; Linfante A; Gamm H
    Anaesthesist; 1982 Feb; 31(2):61-7. PubMed ID: 6177264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retarded elimination of a high-molecular enzyme-substrate-complex after hydroxyethyl-starch-infusion.
    Kirch W; Köhler H; Horstmann HJ
    Arch Toxicol Suppl; 1978; (1):335-8. PubMed ID: 79408
    [No Abstract]   [Full Text] [Related]  

  • 8. Transfusion of hydroxyethylated amylopectin-protected frozen blood in man. I. Plasma clearance and renal excretion of the cryoprotectant.
    Mishler JM; Parry ES
    Vox Sang; 1979; 36(6):337-41. PubMed ID: 91262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hetastarch: an overview of the colloid and its metabolism.
    Hulse JD; Yacobi A
    Drug Intell Clin Pharm; 1983 May; 17(5):334-41. PubMed ID: 6190620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antishock blood substitute based on hydroxyethyl starch].
    Polushina TV; Prostakova TM; Bogino NA
    Probl Gematol Pereliv Krovi; 1980 Mar; 25(3):40-4. PubMed ID: 6154296
    [No Abstract]   [Full Text] [Related]  

  • 11. In vitro comparison of the erythrocyte sedimenting properties of dextran, hydroxyethyl starch and a new low-molecular-weight hydroxyethyl starch.
    Strauss RG
    Vox Sang; 1979; 37(5):268-71. PubMed ID: 93347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Morphological characteristics of the sequelae from the parenteral administration of solutions of hydroxyethyl starch].
    Prostakova TM; Glasko EN; Khokhlova MP; Polushina TV
    Arkh Patol; 1986; 48(7):43-7. PubMed ID: 2428336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Physico-chemical and biological properties of a new plasma substitute based on hydroxyethylated starch].
    Kudriashov LI; Dombrovskiĭ VA; Alekseeva GS; Iarovaia SM; Chlenov MA
    Bioorg Khim; 1986 Jun; 12(6):812-8. PubMed ID: 2430577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macroamylasemia induced by hydroxyethyl starch--confirmation by gel filtration analysis of serum and urine.
    Mishler JM; Dürr GH
    Am J Clin Pathol; 1980 Oct; 74(4):387-91. PubMed ID: 6158858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macroamylasaemia following the infusion of low molecular weight-hydroxyethyl starch in man.
    Mishler JM; Dürr HK
    Eur Surg Res; 1979; 11(4):217-22. PubMed ID: 93539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serial infusion effects of hydroxyethyl starch on ESR, blood typing and crossmatching and serum amylase levels.
    Janes AW; Mishler JM; Lowes B
    Vox Sang; 1977; 32(3):131-4. PubMed ID: 67712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of dextran 60,000(D 60) and hydroxyethyl starch 450,000 (HES 450) on lymphocyte transformation].
    Khosropour R; Cerni C; Lackner F; Watzek C
    Anaesthesist; 1983 Jan; 32(1):25-7. PubMed ID: 6189413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of HES in cardiac surgery.
    Belcher P
    Ann Thorac Surg; 1985 Oct; 40(4):416. PubMed ID: 2413811
    [No Abstract]   [Full Text] [Related]  

  • 19. Hydroxyethyl starch: an agent for hypovolemic shock treatment.
    Mishler JM; Borberg H; Emerson PM; Gross R
    J Surg Res; 1977 Oct; 23(4):239-45. PubMed ID: 70572
    [No Abstract]   [Full Text] [Related]  

  • 20. [Blood volume replacement using hydroxyethyl starch or Dextran 60].
    Hölscher B
    Infusionstherapie (1973); 1974 Apr; 1(4):281-5. PubMed ID: 4142945
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.